Mendus signs agreement with Olivia Newton-John Cancer Research Institute to expand clinical development of vididencel in AML

What we doOur approachPipelineTechnologyPatient Stories
About usManagementBoardClinical Advisory BoardCareers
Newsroom
InvestorsPress releases

Back
Mendus signs agreement with Olivia Newton-John Cancer Research Institute to expand clinical development of vididencel in AML
 8:00:00 AM

Keep reading
Notice of Annual General Meeting in Mendus AB (publ)Read